Background. Vascular access-associated infections in patients on hemodialysis is not well described except in the United States, where there is a national surveillance system focused on hemodialysis patients. The purpose of the study is to describe the epidemiology and identify risk factors for vascular access-associated infection (VAI) in patients on hemodialysis, using data collected through Dialysis Surveillance Network Japan (DSNJ), a voluntary multicenter VAI surveillance network.
Methods. Data collected through DSNJ from January 2008 to December 2017 were used. Incidence of VAI was calculated by the number of infection per 1,000 dialysis sessions.
Results. Forty-five healthcare facilities participated. The overall incidence of VAI throughout the period differed greatly by the type of access; 0.05 (125 VAI in 2,332,719 dialysis sessions) for arteriovenous fistula (AVF), 0.16 (16/101,766) for superficialization of brachial artery (SBA), 0.60 (69/114,139) for arteriovenous graft (AVG), 1.45 (104/71,765) for cuffed catheter (CC) and 9.17 (394/42,943) for noncuffed catheter (NCC). Differences between each of these incidences were statistically significant. Of note, NCC had significantly higher risk for VAI than any other type of access. Diabetes was also a risk factor for VAI in patients on hemodialysis with either NCC or CC (RR 1.42, 95% CI: 1.15-1.76). NCC used at the induction of hemodialysis was more likely to be complicated with VAI than NCC used as a temporary substitute for other permanent access due to its trouble (RR 1.55, 95% CI: 1.18-2.04). There was a seasonal variation in the incidence of VAI, especially for AVF and CC, with the highest peak in summer.
Conclusion. The risk of VAI varied among different types of VA. The use of NCC is discouraged due to its extremely higher risk of VAI compared with other type of VA including CC. In order to avoid the emergent use of NCC at the induction phase, chronic kidney disease patients should be well prepared by evaluating their renal function and creating AVF or AVG in advance. Finally, patients on hemodialysis should be well educated regarding the risk of VAI in summer.
Disclosures. Background. Measles is a highly contagious disease and nosocomial outbreaks have been documented. Pediatric hospitals are particularly at risk due to the concentration of susceptible patients such as infants <12 months old or with immunocompromised status. Effective strategies to control nosocomial measles transmission will be critical for successful measles elimination. We reviewed the impact of our hospital's approach for post-exposure prophylaxis (PEP) against measles.
Methods. We extracted details of all measles intra-hospital exposure events in our pediatric hospital in April 2016 to December 2016. For this analysis, we only included close contacts who were defined as patients within the same cubicle as the measles index case for any duration prior to the index case isolation. All close contacts were followed up with a telephone call to check if they developed fever or rash after the incubation period. In May 2016, we implemented measles PEP [(measles, mumps, and rubella (MMR) vaccine or immune globulin (IG)) for close contacts in accordance to their age and immunity status. Details of events pre-vs. post-PEP implementation were analysed.
Results. Prior to PEP implementation, there were two exposure events resulting in eight close contacts, of which seven (87.5%) had no MMR vaccination and one had received a single dose. Subsequently, two (25%) developed confirmed measles approximately 2 weeks post-exposure. Post-PEP implementation, there were four exposure events resulting in 14 close contacts, of which all had no MMR vaccination. Five patients were positive for measles serology. Measles PEP was given to eight patients, where seven received IG and one (7.1%) had MMR vaccination. At follow-up, two of the 14 close contacts reported fever during the incubation period but none developed measles. One was already known to be measles serology positive and the second who was given IG was diagnosed with unresolved RSV.
Conclusion. Implementation of measles PEP in our hospital prevented secondary nosocomial transmission amongst susceptible close contacts in the same cubicle.
Disclosures. 
